[PDF][PDF] Beyond epithelial damage: vascular and endothelial contributions to idiopathic pulmonary fibrosis
J May, JA Mitchell, RG Jenkins - Journal of Clinical …, 2023 - Am Soc Clin Investig
Idiopathic pulmonary fibrosis (IPF) is a progressive scarring disease of the lung with poor
survival. The incidence and mortality of IPF are rising, but treatment remains limited …
survival. The incidence and mortality of IPF are rising, but treatment remains limited …
[HTML][HTML] Beyond epithelial damage: vascular and endothelial contributions to idiopathic pulmonary fibrosis
J May, JA Mitchell, RG Jenkins - The Journal of Clinical …, 2023 - ncbi.nlm.nih.gov
Idiopathic pulmonary fibrosis (IPF) is a progressive scarring disease of the lung with poor
survival. The incidence and mortality of IPF are rising, but treatment remains limited …
survival. The incidence and mortality of IPF are rising, but treatment remains limited …
Beyond epithelial damage: vascular and endothelial contributions to idiopathic pulmonary fibrosis
J May, JA Mitchell, RG Jenkins - The Journal of clinical …, 2023 - pubmed.ncbi.nlm.nih.gov
Idiopathic pulmonary fibrosis (IPF) is a progressive scarring disease of the lung with poor
survival. The incidence and mortality of IPF are rising, but treatment remains limited …
survival. The incidence and mortality of IPF are rising, but treatment remains limited …
Beyond epithelial damage: vascular and endothelial contributions to idiopathic pulmonary fibrosis.
J May, JA Mitchell, RG Jenkins - The Journal of Clinical Investigation, 2023 - europepmc.org
Idiopathic pulmonary fibrosis (IPF) is a progressive scarring disease of the lung with poor
survival. The incidence and mortality of IPF are rising, but treatment remains limited …
survival. The incidence and mortality of IPF are rising, but treatment remains limited …
Beyond epithelial damage: vascular and endothelial contributions to idiopathic pulmonary fibrosis
J May, JA Mitchell, RG Jenkins - Journal of Clinical …, 2023 - search.proquest.com
Idiopathic pulmonary fibrosis (IPF) is a progressive scarring disease of the lung with poor
survival. The incidence and mortality of IPF are rising, but treatment remains limited …
survival. The incidence and mortality of IPF are rising, but treatment remains limited …
Beyond epithelial damage: vascular and endothelial contributions to idiopathic pulmonary fibrosis.
J May, JA Mitchell, RG Jenkins - The Journal of Clinical Investigation, 2023 - europepmc.org
Idiopathic pulmonary fibrosis (IPF) is a progressive scarring disease of the lung with poor
survival. The incidence and mortality of IPF are rising, but treatment remains limited …
survival. The incidence and mortality of IPF are rising, but treatment remains limited …